CXCR2 and neoplasm: A second retrospective cohort of synchronously resected primary tumours and matched liver metastases was assessed via immunohistochemistry (IHC) for protein expression of the CXCL8 receptor CXCR2 to determine any association with clinicopathological features in the metastatic setting.